跳至主要内容
临床试验/NCT06381895
NCT06381895已完成不适用

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2023年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,200
试验地点
1
主要终点
Tumour-infiltrating lymphocytes (TIL)

研究概览

简要总结

The aim of this study was to develop an radiomic model based on CT images to evaluate markers of the bladder cancer microenvironment, such as TSR,TIL, and IP. Secondly, the association of the radiomic model with clinical outcomes and immunotherapy response was investigated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age;
  • Performing TURB-t or RC during 2010-2022;
  • The primary lesion was located in the bladder, and the pathological diagnosis was urothelial carcinoma;
  • Complete clinical information, pathological data, preoperative pelvic enhanced CT and follow-up records;

排除标准

  • Patients with distant metastasis;
  • Combined with other malignant tumors or malignant tumor treatment history
  • Malignant tumors of upper urinary tract;
  • Clinical information, pathological data, preoperative pelvic enhanced CT and follow-up records were missing;
  • Other situations in which the researcher considers it inappropriate to participate in this study.

结局指标

主要结局

Tumour-infiltrating lymphocytes (TIL)

时间窗: 1 year

TILs were evaluated using paraffin-embedded tumour tissue samples stained with H\&E according to established protocols.

次要结局

  • overall survival(1 year)
  • cancer-specific survival(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验